Get the Stockscreener App
1.61
1.26%
0.02
Biovie Inc stock is traded at $1.61, with a volume of 111.01K.
It is up +1.26% in the last 24 hours and up +4.89% over the past month.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
See More
Previous Close:
$1.59
Open:
$1.59
24h Volume:
111.01K
Relative Volume:
0.66
Market Cap:
$12.14M
Revenue:
-
Net Income/Loss:
$-25.56M
P/E Ratio:
-0.3096
EPS:
-5.2
Net Cash Flow:
$-19.35M
1W Performance:
+11.03%
1M Performance:
+4.89%
6M Performance:
+47.71%
1Y Performance:
-41.88%
1-Day Range:
$1.56
$1.70
1-Week Range:
$1.42
$1.70
52-Week Range:
$0.62
$9.56
Biovie Inc Stock (BIVI) Company Profile
Name
Biovie Inc
Sector
Industry
Phone
775-888-3162
Address
680 W NYE LANE, CARSON CITY
Compare BIVI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.61 | 11.98M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-22-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-15-21 | Initiated | B. Riley Securities | Buy |
Biovie Inc Stock (BIVI) Latest News
Can BioVie Inc. stock sustain institutional interestJuly 2025 Review & Low Drawdown Trading Strategies - Newser
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pocono Record
BioVie Inc. (BIVI) -5.7% in After-hours: Stock Declines Amid Routine Trading Conditions - Stocks Telegraph
BioVie (NASDAQ:BIVI) Shares Up 0.3% – Here’s What Happened - Defense World
How BioVie Inc. stock compares to industry benchmarksTake Profit & Smart Swing Trading Techniques - BỘ NỘI VỤ
BIVI SEC FilingsBiovie Inc 10-K, 10-Q, 8-K Forms - Stock Titan
[S-8] BIOVIE INC. Employee Benefit Plan Registration | BIVI SEC FilingForm S-8 - Stock Titan
BIVIW | BioVie Inc. Warrant Stock Data, Price & News - Quiver Quantitative
BioVie Inc. (BIVI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What drives BioVie Inc stock pricePrice Support Zones & Free Record-Breaking Gains - earlytimes.in
What catalysts could drive BioVie Inc. stock higherMarket Performance Summary & Consistent Growth Stock Picks - newser.com
Biotech Stocks Swing After Hours: Delcath Rises On Buyback, BioVie And Cassava Rebound - Nasdaq
Will BioVie Inc. stock outperform Nasdaq index2025 Market Overview & Daily Oversold Bounce Ideas - newser.com
How BioVie Inc. stock performs in stagflation2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com
Is BioVie Inc. stock safe for conservative investorsJuly 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com
How currency fluctuations impact BioVie Inc. stockOil Prices & Weekly Watchlist of Top Performers - newser.com
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9 - The Manila Times
[EFFECT] BIOVIE INC. SEC Filing - Stock Titan
BioVie (NASDAQ: BIVI) Plans December Investor Webinar on NE3107 and BIV201 Programs - Stock Titan
Key metrics from BioVie Inc.’s quarterly dataQuarterly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
Using Ichimoku Cloud for BioVie Inc. technicalsMarket Risk Analysis & Growth Focused Entry Reports - newser.com
Kameel D. Farag Net Worth (2025) - GuruFocus
Amy Suzon Chappell Net Worth (2025) - GuruFocus
BioVie Inc Stock Analysis and ForecastTrend Following Strategies & High Profit Trading Alerts - earlytimes.in
Analyzing recovery setups for BioVie Inc. investorsMarket Trend Review & Technical Buy Zone Confirmations - newser.com
Chart based exit strategy for BioVie Inc.Breakout Watch & Verified High Yield Trade Plans - newser.com
Can BioVie Inc. stock beat analyst upgradesWeekly Gains Report & AI Powered Market Trend Analysis - newser.com
Biovie Inc Stock (BIVI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):